Windamere Venture Partners

Windamere Venture Partners is a venture capital firm specializing in the creation and early-stage funding of life science companies. The firm operates on a venture company creation model, actively building and incubating biotechnology ventures from nascent scientific concepts. It focuses on seed and early-stage investments, providing strategic involvement and resources to develop impactful advancements within the life sciences sector.

The firm was founded in 1999 by Scott Glenn, a prolific entrepreneur with significant experience in the biomedical field. Glenn established Windamere Venture Partners to leverage his extensive background in founding and commercializing numerous successful life science companies, pioneering a hands-on, deeply involved approach to venture building. This foundation reflects a deep understanding of the unique challenges and opportunities within the biotechnology landscape.

Windamere Venture Partners primarily supports early-stage life science and biotechnology companies that seek more than just capital, benefiting from active guidance and participation in their development. The firm’s vision is to identify and nurture innovative biomedical ventures, transforming scientific breakthroughs into viable companies that deliver new therapies and technologies. It aims to foster significant advancements across healthcare by fostering groundbreaking ventures.